Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06850740Enrolling by invitation
Randomised, double-blind trial of ondansetron in hypotension (2 arms), sponsored by Suez Canal University. Primary endpoint: Total Ephedrine Consumption. Started Mar 2025; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06850740.